The CDC's new biomarker report tracks nutrition patterns, but supplement comparisons are descriptive population data—not diagnoses or proof of benefit.
A new Centers for Disease Control and Prevention report brings together decades of U.S. measurements for vitamins, minerals, and other nutrition-related indicators. Its breadth is useful—but the word “biomarker” can make population data sound like a personal diagnosis. The report does not tell an individual whether to start a supplement, and its comparisons of supplement users with nonusers do not prove that supplements caused a difference. Understanding what the data can and cannot say is more useful than treating a national survey as a personal scorecard.
What the report measures
The CDC’s 2026 National Nutrition Report organizes up to 131 biochemical indicators measured in the National Health and Nutrition Examination Survey (NHANES) from 1999 through August 2023. The most recent period, August 2021–August 2023, includes 50 biomarkers—not all 131. NHANES combines interviews, physical examinations, dietary and supplement questions, and laboratory testing to produce estimates for the U.S. population. In other words, the report is built to describe patterns across groups and time, not to return a diagnosis for any one reader.
A biomarker is a measurable biological value, such as a concentration in blood or urine. It can help researchers understand population exposure or nutritional status, but its meaning depends on the specific nutrient, the test, the relevant age group, and the scientific evidence connecting the value with health outcomes. Some nutrients have established reference ranges for particular uses; for other indicators, the relationship between a measured level and disease risk remains uncertain. A number by itself is not a complete assessment of someone’s diet or health.
Supplement comparisons are descriptive, not a trial
One addition to the 2026 release is a way to view trends by whether someone reported taking any dietary supplement in the previous 30 days. That can help researchers ask better questions about how biomarker patterns differ across populations. But it is not a randomized experiment. People who take supplements may differ from nonusers in age, income, diet, health status, medication use, or access to care. The report’s comparison does not isolate the effect of a particular pill, dose, or ingredient from those other influences.
Nor does a higher measured concentration automatically mean “healthier.” The report emphasizes that biomarker levels can reflect nutrients from both foods and fortified products as well as supplements; they may also be affected by illness, metabolism, environmental exposure, or other factors. The CDC describes results as descriptive statistics and says that differences between groups do not necessarily indicate a health problem. The report is not designed to rate the nation’s overall health or set disease-risk thresholds for every marker.
A population trend can guide better research, but it cannot tell one person what to take.
How readers can use the findings
The report can help public-health researchers monitor whether nutrient-related indicators shift over time or vary by age and other characteristics. It may help identify questions for additional research—for example, whether food fortification has changed population levels of a particular nutrient. It can also help policymakers understand where more data may be needed. Those are meaningful uses even when a report does not make a clinical recommendation.
For readers, the practical lesson is to avoid turning an average into an individual target. A population average does not show whether a specific person is deficient, has an excess, or would benefit from supplementation. It is also important to check which survey period and which marker a claim refers to: the report spans many years, and not every biomarker was measured in every NHANES cycle or for the same age groups. The latest period’s 50 available biomarkers should not be described as a complete update of all 131.
Questions to ask before changing a supplement routine
The National Institutes of Health Office of Dietary Supplements recommends evaluating products and health claims carefully; evidence can differ substantially from one supplement to another. A consumer report cannot replace that product-specific evidence or a clinician’s advice. Before starting, stopping, or combining supplements, consider the reason for taking them, possible interactions with medicines, the dose, and whether a clinician has recommended testing. People with a diagnosed condition, pregnancy, or prescribed treatment should seek individualized professional advice rather than relying on a public-health chart.
The CDC report is best understood as a map of selected nutrition indicators across a population—not a shopping list, diagnosis, or promise of benefit. Its new supplement-use breakdown may help scientists formulate more precise questions, but it cannot establish cause and effect. Readers who keep that distinction in mind can appreciate the report’s scale while avoiding conclusions its data were not designed to support.
References & Primary Sources
- CDC’s 2026 Nutrition Report Presents Data for 131 Biomarkers from NHANES 1999–August 2023 — Current Developments in Nutrition (2026)
- CDC Releases 2026 National Nutrition Report — U.S. Centers for Disease Control and Prevention (2026)
- Executive Summary — U.S. Centers for Disease Control and Prevention (2026)
- Common Questions — U.S. Centers for Disease Control and Prevention (2026)
- About NHANES — U.S. Centers for Disease Control and Prevention (2024)
- Frequently Asked Questions—Office of Dietary Supplements — National Institutes of Health (accessed 2026)
- Recent Approaches to Assessing Nutritional Adequacy and Exploring Chronic Disease — National Academies of Sciences, Engineering, and Medicine (2017)
- Fresh Cut Fruits and Vegetables — Peggy Greb/U.S. Department of Agriculture (Public Domain)